Investor Dashboard

Biotechnology stocks are delivering a classic split-screen session in the U.S. market today: biotech ETFs are slipping, but a handful of single-name biotech movers are swinging sharply on FDA updates, clinical data, and year-end dealmaking.
Company hubNASDAQ:ALDX
Follow the latest ALDX (ALDX) company news, earnings coverage and investor analysis from TS2 Tech.